Ụdị Hydrobromide Raw Galantamine (69353-21-5)

Akwukwo hydrogromide Raw Galantamine (69353-21-5) video

Ụdị Hydrobromide Raw Galantamine (69353-21-5) Description

Ngwakọta Ugwu Galantamine Hydrobromide bụ benzazepine nke sitere na norbelladine. A na-achọta ya na GALANTHUS na ndị ọzọ AMARYLLIDACEAE. Ọ bụ onye na-emepụta cholinesterase nke ejiji iji gbanwee mmetụta muscular nke GALLAMINE TRIETHIODIDE na TUBOCURARINE ma a mụọ ya dịka ọgwụgwọ maka ọrịa ALZHEIMER na nsogbu ndị ọzọ na-ahụ maka nsogbu usoro nsogbu.

Raw Galantamine Hydrobromide ntụ ntụ bụ ụdị nnu hydrobromide nke galantamine, alkaloid dị elu nke enwetara na synthetically ma ọ bụ n'ụzọ nkịtị site na bọlbụ na okooko osisi nke Narcissus na ọtụtụ usoro ndị ọzọ nke ezinụlọ Amaryllidaceae nwere ihe omume anticholinesterase na mmezi neurocognitive. Galantamine na-asọmpi na ntụgharị na-egbochi acetylcholinesterase, si otú ahụ na-eme ka ịta ahụhụ na imeziwanye ihe nke acetylcholine (Ach). Tụkwasị na nke ahụ, galantamine bụ ligand maka ndị na-anabata acetylcholine nicotinic, nke nwere ike ime ka ntọhapụ presynaptic nke Ach ma mee ka ndị nabatara postsynaptic rụọ ọrụ. Onye ọrụ a nwere ike imeziwanye ọrụ nhụjuanya na ọrịa Alzheimer dị nro ma dị nwayọọ ma nwee ike belata mgbaàmà nke nghọta na-akwalite ị smokingụ sịga.

Akwukwo hydrogromide Raw Galantamine (69353-21-5) Smmezi

raw Hydrobromide Galantamine ntụ ntụ (69353-21-5) Nkọwa

Galantamine Hydrobromide bụ ụdị nnu hydrobromide nke galantamine, nke a na-enweta nke ọma na nke sitere na bọlbụ na okooko osisi nke Narcissus na ọtụtụ usoro ndị ọzọ nke ezinụlọ Amaryllidaceae nwere usoro anticholinesterase na mmezi neurocognitive. Galantamine na-asọmpi na ntụgharị na-egbochi acetylcholinesterase, si otú ahụ na-eme ka ịta ahụhụ na imeziwanye ihe nke acetylcholine (Ach). Tụkwasị na nke ahụ, galantamine bụ ligand maka ndị na-anabata acetylcholine nicotinic, nke nwere ike ime ka ntọhapụ presynaptic nke Ach ma mee ka ndị nabatara postsynaptic rụọ ọrụ. Onye ọrụ a nwere ike imeziwanye ọrụ nhụjuanya na ọrịa Alzheimer dị nro ma dị nwayọọ ma nwee ike belata mgbaàmà na-emetụta abstinence na-akwalite ị relaụ sịga.

Hydrobromide Galantamine ntụ ntụ (69353-21-5) Ime ihe?

Galantamine bụ phenanthrene alkaloid na onye na-agbanwe agbanwe, asọmpi acetylcholinesterase inhibitor. Enweghi mmekorita ya na ndi ozo acetylcholinesterase. Usoro usoro ihe Galantamine chọrọ na-agụnye igbochi igbochi acetylcholinesterase, nke na-egbochi hydrolysis nke acetycholine, na-eduga n'ịba ụba nke acetylcholine na cholinergic synapses. Galantamine na-ejikọkwa ihe na nicotinic acetylcholine na-anabata ma nwee ike ime ka ndị agonists rụọ ọrụ (dị ka acetylcholine) na ndị nnabata a.

uru of Hydrobromide Galantamine ntụ ntụ (69353-21-5)

• Mee ka arụ ọrụ na-arụ ọrụ mma
• Na-ebelata mmịfụ
• Ọ bụ Antioxidant
• Nwere ike igbochi ọgwụ nsị
• Nwere ike ịnagide ọrịa shuga
• Nwere ike ịnagide oke oke
• Na-egosi Dreamid Dreaming
• Nwere ike iwepụ ihe mgbaàmà nke Autism
• Nwere ike inyere aka na Schizophrenia
• Na-eme ka ọrịa ogbu na nkwonkwo gbanwee
• Nwere ike inyere gị aka ịkwụsị ise siga
• Na-egbochi Ọrịa Brain

-atụ aro Hydrobromide Galantamine ntụ ntụ (69353-21-5) Ọgwụgwọ

Kọlọsi Hydrobromide Galantamine 16 mg / ụbọchị bụ usoro ọgwụgwọ kachasị mma maka ndị ọrịa nwere AD dị arọ, dị ka nrụpụta yiri nke a na-ahụ na 24 mg / day dose. Otú ọ dị, ndị ọrịa nwere AD dị ala ga-enweta uru ndị ọzọ site na galantamine 24 mg / ụbọchị.

mmetụta of Hydrobromide Galantamine ntụ ntụ (69353-21-5)

Mmetụta ndị na-agakarị nke Galantamine Hydrobromide ntụ ntụ gụnyere mgbatị ahụ na adịghị ike, ihe omume cardio-respiratory, nsogbu akpụkpọ ahụ, na urinary incontinence. Nara nnukwu ọgwụ dị iche iche nke Galantamine na-enweghị iwuli nwayọ elu nwekwara ike ibute nrọ na nchekasị.

Na mgbakwunye na mmetụta ndị a, mmekọrịta Galantamine na ọgwụ ndị ọzọ nwere ike ịkpata nsogbu ahụ ike. A gwara ya ka ị ghara iji oge Galantamine mee ihe mgbe ị na-ewere ọgwụ ndị ọzọ a na-etinye site n'ime ụzọ imeju ahụ (usoro cytochrome nke hepatic).

Obi dị m ụtọ, ọtụtụ n'ime mmetụta ndị dị n'elu bụ ndị dị ụkọ ma eleghị anya a ga-ezere dosing.